Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Board Meeting | 24 December 2025

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Apollo Hospitals received NSE's 'no objection' observation letter on December 23, 2025, for its composite scheme involving demerger of an identified business undertaking into Apollo Healthtech Limited, amalgamation of two transferor companies, and consequent listing on NSE and BSE. The scheme, approved by CCI on September 24, 2025, remains subject to NCLT approval, shareholder/creditor consent, and compliance with 11 detailed regulatory conditions including enhanced disclosures on pending legal actions, valuation methodologies, and financial details. Apollo Healthtech's listing is discretionary and conditional on Information Memorandum submission and strict 60-day listing timeline post-NCLT order.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day